FeatureName:distant_metastasis_pathologic_spread|Type:BIN|StatisticMethod:ranktest|GroupComparison:m0/m1|Statistics: 203.000000|Direction:-1|PValue:4.43295e-03|FDR:7.70225e-02;FeatureName:lymphatic_invasion_present|Type:BIN|StatisticMethod:ranktest|GroupComparison:yes/no|Statistics:1079.000000|Direction: 1|PValue:2.13160e-02|FDR:3.52811e-01;FeatureName:residual_tumor|Type:CAT|StatisticMethod:kruskal|GroupComparison:r0/r2/rx/r1|Statistics:  10.016203|Direction: 1|PValue:1.84289e-02|FDR:1.60230e-01;FeatureName:tumor_stage|Type:CAT|StatisticMethod:kruskal|GroupComparison:stage ii/stage i/stage iii/stage iv|Statistics:   9.990827|Direction: 1|PValue:1.86443e-02|FDR:1.61972e-01;FeatureName:MSI_status_TCGAPaper_threegroup|Type:CAT|StatisticMethod:kruskal|GroupComparison:MSS/MSI-L/MSI-H|Statistics:   8.304444|Direction: 1|PValue:1.57294e-02|FDR:8.39819e-02;FeatureName:MSI_status_TCGAPaper_twogroup|Type:BIN|StatisticMethod:ranktest|GroupComparison:MSS/MSI|Statistics: 918.000000|Direction: 1|PValue:1.62818e-02|FDR:8.70448e-02;FeatureName:MLH1_silencing|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 618.000000|Direction: 1|PValue:1.69424e-03|FDR:2.59377e-02;FeatureName:hypermutated|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 753.000000|Direction: 1|PValue:1.57507e-04|FDR:1.56382e-03;FeatureName:silent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.379002|Direction:-1|PValue:1.02690e-03|FDR:7.51255e-03;FeatureName:nonsilent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.404660|Direction:-1|PValue:4.22465e-04|FDR:5.87226e-03;FeatureName:DNAH2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 720.000000|Direction: 1|PValue:8.38405e-03|FDR:2.00283e-01;FeatureName:TP53_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 637.000000|Direction:-1|PValue:1.90668e-02|FDR:1.01934e-01;FeatureName:RYR1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 718.000000|Direction: 1|PValue:2.64797e-02|FDR:2.52738e-01;FeatureName:TTN_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics: 603.000000|Direction:-1|PValue:1.11546e-02|FDR:1.98930e-01;FeatureName:MUC16_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 913.000000|Direction: 1|PValue:2.59866e-03|FDR:2.58010e-02;FeatureName:FAM123B_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 511.000000|Direction: 1|PValue:1.60995e-02|FDR:4.35478e-01;FeatureName:20q11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.477309|Direction: 1|PValue:2.57655e-06|FDR:2.78582e-05;FeatureName:20q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.528966|Direction: 1|PValue:1.17075e-07|FDR:1.80816e-06;FeatureName:13q12.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.283399|Direction: 1|PValue:7.45952e-03|FDR:6.09926e-02;FeatureName:13q12.13_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.309233|Direction: 1|PValue:3.37216e-03|FDR:3.34808e-02;FeatureName:13q22.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.278757|Direction: 1|PValue:8.54014e-03|FDR:5.93540e-02;FeatureName:6p21.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.401297|Direction: 1|PValue:1.06683e-04|FDR:1.48290e-02;FeatureName:20q13.31_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.467779|Direction: 1|PValue:4.32122e-06|FDR:5.46045e-05;FeatureName:19p13.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.339232|Direction: 1|PValue:1.22404e-03|FDR:1.70141e-01;FeatureName:16p11.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.390462|Direction: 1|PValue:1.69282e-04|FDR:1.52235e-03;FeatureName:16q23.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.360568|Direction: 1|PValue:5.58688e-04|FDR:4.85361e-03;FeatureName:1p36.11_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.381558|Direction:-1|PValue:2.44502e-04|FDR:5.44645e-03;FeatureName:18q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.213496|Direction:-1|PValue:4.58012e-02|FDR:1.04367e-01;FeatureName:6p25.3_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.296288|Direction: 1|PValue:5.06421e-03|FDR:2.34642e-01;FeatureName:21q11.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.246817|Direction:-1|PValue:2.04365e-02|FDR:9.40411e-01;FeatureName:18q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.251921|Direction:-1|PValue:1.78960e-02|FDR:5.18239e-02;FeatureName:7q31.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.298875|Direction: 1|PValue:4.67571e-03|FDR:5.90839e-02;FeatureName:22q13.32_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.275607|Direction:-1|PValue:9.34961e-03|FDR:4.33198e-01;FeatureName:19p13.3_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.331505|Direction: 1|PValue:1.60472e-03|FDR:2.23057e-01;FeatureName:17p12_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.250526|Direction:-1|PValue:1.85618e-02|FDR:1.17277e-01;FeatureName:15q11.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.245997|Direction:-1|PValue:2.08723e-02|FDR:4.06670e-01;FeatureName:15q21.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.264330|Direction:-1|PValue:1.28242e-02|FDR:2.49888e-01;FeatureName:18p11.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.390278|Direction:-1|PValue:1.70590e-04|FDR:1.82400e-03;FeatureName:1p13.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.263384|Direction:-1|PValue:1.31610e-02|FDR:1.57807e-01